Chairman
Repligen Corp (RGEN)Equibles does not estimate personal net worth.
Get an email with a short summary when Repligen Corp publishes a filing, an earnings call transcript or a press release.
Get RGEN alertsTony J. Hunt is recorded as Chairman at Repligen Corp (RGEN) since September 1, 2024. Repligen Corp reported in an 8-K filed January 6, 2026 that Tony J. Hunt retired as member of the Board, effective March 13, 2026. Repligen Corp reported in an 8-K filed January 6, 2026 that Tony J. Hunt retired as Executive Chair of the Board, effective March 13, 2026. Repligen Corp reported in an 8-K filed June 14, 2024 that Tony J. Hunt was appointed Executive Chair of the Repligen board of directors, effective September 1, 2024. The proxy statement of Repligen Corp reports total compensation of $20,304,850 for Tony J. Hunt in fiscal 2024, including a base salary of $733,333. Disclosed compensation is on record for 8 fiscal years. Repligen Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Repligen Corp includes Olivier Loeillot (CEO and Board Member), Dr. Martin D. Madaus (Chairman and Board Member), Martin D. Madaus (Chairman) and 7 others.
“Dr. Madaus will succeed Tony J. Hunt, who is currently serving as the Executive Chair of the Board, following his previously announced March 2026 retirement, which shall be on the Effective Date, at which time Mr. Hunt will retire as a member of the Board.”
“Dr. Madaus will succeed Tony J. Hunt, who is currently serving as the Executive Chair of the Board, following his previously announced March 2026 retirement, which shall be on the Effective Date, at which time Mr. Hunt will retire as a member of the Board.”
2024-09-01–present
2024-09-01–2026-03-13
Start not stated–2024-04-01
Last confirmed by a filing; no departure on record
Start not stated–2026-03-13
RGEN
Medical Instruments & Supplies · Healthcare
Chairman
2024-09-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Repligen Corp (RGEN) | Former Chief Executive Officer | $733,333 | $20,304,850 |
| 2023 | Repligen Corp (RGEN) | Former Chief Executive Officer | $880,000 | $7,929,275 |
| 2022 | Repligen Corp (RGEN) | Former Chief Executive Officer | $800,000 | $7,713,930 |
| 2021 | Repligen Corp (RGEN) | Chief Executive Officer | $761,000 | $7,765,070 |
| 2020 | Repligen Corp (RGEN) | President and CEO | $725,000 | $5,066,061 |
| 2019 | Repligen Corp (RGEN) | President and CEO | $685,000 | $4,424,560 |
| 2018 | Repligen Corp (RGEN) | President and Chief Executive Officer | $600,000 | $13,893,326 |
| 2017 | Repligen Corp (RGEN) | President and Chief Executive Officer | $550,000 | $3,130,587 |
